Proteasome inhibitors: a new perspective for treating autoimmune diseases.
about
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes.Genetics of proteasome diseases.Proteasome inhibitors: possible novel therapeutic strategy for ischemia-reperfusion injury?Proteasome inhibitors as experimental therapeutics of autoimmune diseases.A combination of bortezomib and rituximab yields a dramatic response in a woman with highly refractory immune thrombocytopenic purpura: a case report.Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation.
P2860
Proteasome inhibitors: a new perspective for treating autoimmune diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Proteasome inhibitors: a new perspective for treating autoimmune diseases.
@en
type
label
Proteasome inhibitors: a new perspective for treating autoimmune diseases.
@en
prefLabel
Proteasome inhibitors: a new perspective for treating autoimmune diseases.
@en
P1433
P1476
Proteasome inhibitors: a new perspective for treating autoimmune diseases
@en
P2093
Alessandra Fierabracci
P304
P356
10.2174/138945012803530053
P577
2012-12-01T00:00:00Z